Recordati board backs €10.7bn CVC take-private offer

Recordati’s board has largely agreed to a €10.7bn offer to take the company private, led by private equity firm CVC Capital Partners and Belgian investment group Groupe Bruxelles Lambert. However, four independent directors disagreed with the move, raising questions about the deal's future. This deal, if finalized, would mark one of the largest buyouts in the pharmaceutical sector, potentially reshaping the company's strategic direction and financial landscape. Investors and analysts are watching closely to see how this will impact Recordati’s market position and operational focus.